Year: 2025

Sapu Nano Unveils First-in-Human Clinical Trial of Sapu-003 at 8th Australian Translational Breast Cancer Research Symposium

Using Sapu Nano’s proprietary Deciparticle™ technology, Sapu-003 delivers everolimus intravenouslySYDNEY, Australia, Oct. 08, 2025 (GLOBE NEWSWIRE) -- via IBN –...

Nexalin Technology Announces Additional Positive Clinical Results in Alzheimer’s Disease with Gen-2 SYNC Neurostimulation Device

40-Hz DIFS™ significantly improves cognitive performance and brain connectivity in peer-reviewed clinical trial Results published in Radiology, the flagship journal...

Starton Therapeutics to Share Innovative Lenalidomide Delivery Technology on Labroots Webinar Sponsored by Primetech Corporation

PARAMUS, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with...

Verisma Recognized by Industry Clients as Top Release of Information Solution in Black Book’s 2026 Survey, Extending Market Leadership Into Seventh Consecutive Year

error: Content is protected !!